BASF's short interest surged by 900.0%, calling into question the stock's valuation. Despite the turbulence, several sources suggest that investing in this fast-paced, momentum stock could be a bargain. Still, this comes amid news of the company's billion-euro investment(project) in Indonesia being scrapped, profit warnings and slight Q1 earnings dip taking a toll on German shares. Nonetheless, BASF has been striking several partnerships recently, with Encina for a long-term recycled benzene deal and Vattenfall partner Vestas for Wind Turbines, perhaps diversifying its portfolio.
Although some suggest the stock has been overvalued, BASF continues to remain popular with investors. With a recent volume recovery and the unveiling of AdBlue ZeroPCF with a smaller carbon footprint, BASF seems to be evolving, looking to broaden its offerings. This comes despite analysts' 'reduce' rating and concerns over a strained balance sheet. The company also started paying out larger dividends than last year, attracting investment. Near the end of these events, BASF unveiled a new natural flavor expanding the Isobionics portfolio and divested its bioenergy enzymes business.
BASF Stocks News Analytics from Wed, 30 Aug 2017 07:00:00 GMT to Sat, 29 Jun 2024 11:19:08 GMT - Rating 5 - Innovation 6 - Information 8 - Rumor -4